BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 34987433)

  • 21. Cross-cultural Validation of the 5-Factor Structure of Negative Symptoms in Schizophrenia.
    Ahmed AO; Kirkpatrick B; Galderisi S; Mucci A; Rossi A; Bertolino A; Rocca P; Maj M; Kaiser S; Bischof M; Hartmann-Riemer MN; Kirschner M; Schneider K; Garcia-Portilla MP; Mane A; Bernardo M; Fernandez-Egea E; Jiefeng C; Jing Y; Shuping T; Gold JM; Allen DN; Strauss GP
    Schizophr Bull; 2019 Mar; 45(2):305-314. PubMed ID: 29912473
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The brief negative symptom scale in translation: A review of psychometric properties and beyond.
    Tatsumi K; Kirkpatrick B; Strauss GP; Opler M
    Eur Neuropsychopharmacol; 2020 Apr; 33():36-44. PubMed ID: 32081498
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Avolition as the core negative symptom in schizophrenia: relevance to pharmacological treatment development.
    Strauss GP; Bartolomeo LA; Harvey PD
    NPJ Schizophr; 2021 Feb; 7(1):16. PubMed ID: 33637748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A transnosographic approach of negative symptoms pathophysiology in schizophrenia and depressive disorders.
    Guessoum SB; Le Strat Y; Dubertret C; Mallet J
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Apr; 99():109862. PubMed ID: 31927053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cluster analysis of negative symptoms identifies distinct negative symptom subgroups.
    Paul NB; Strauss GP; Woodyatt JJ; Paul MG; Keene JR; Allen DN
    Schizophr Res; 2022 Aug; 246():207-215. PubMed ID: 35809353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vocational Profile and Correlates of Employment in People With Schizophrenia: The Role of Avolition.
    Ang MS; Rekhi G; Lee J
    Front Psychiatry; 2020; 11():856. PubMed ID: 33192630
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Latent Structure of Negative Symptoms in Schizophrenia.
    Strauss GP; Nuñez A; Ahmed AO; Barchard KA; Granholm E; Kirkpatrick B; Gold JM; Allen DN
    JAMA Psychiatry; 2018 Dec; 75(12):1271-1279. PubMed ID: 30208377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of the COVID-19 pandemic on negative symptoms in individuals at clinical high-risk for psychosis and outpatients with chronic schizophrenia.
    Strauss GP; Macdonald KI; Ruiz I; Raugh IM; Bartolomeo LA; James SH
    Eur Arch Psychiatry Clin Neurosci; 2022 Feb; 272(1):17-27. PubMed ID: 33881621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Auditory N100 gating in patients with schizophrenia: A systematic meta-analysis.
    Rosburg T
    Clin Neurophysiol; 2018 Oct; 129(10):2099-2111. PubMed ID: 30086444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Auditory N100 amplitude deficits predict conversion to psychosis in the North American Prodrome Longitudinal Study (NAPLS-2) cohort.
    Duncan E; Roach BJ; Massa N; Hamilton HK; Bachman PM; Belger A; Carrion RE; Johannesen JK; Light GA; Niznikiewicz MA; Addington JM; Bearden CE; Cadenhead KS; Cannon TD; Cornblatt BA; McGlashan TH; Perkins DO; Tsuang M; Walker EF; Woods SW; Nasiri N; Mathalon DH
    Schizophr Res; 2022 Oct; 248():89-97. PubMed ID: 35994912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disorganization and cognitive impairment in schizophrenia: New insights from electrophysiological findings.
    Vignapiano A; Koenig T; Mucci A; Giordano GM; Amodio A; Altamura M; Bellomo A; Brugnoli R; Corrivetti G; Di Lorenzo G; Girardi P; Monteleone P; Niolu C; Galderisi S; Maj M;
    Int J Psychophysiol; 2019 Nov; 145():99-108. PubMed ID: 30898578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disorganization and real-world functioning in schizophrenia: Results from the multicenter study of the Italian Network for Research on Psychoses.
    Rocca P; Galderisi S; Rossi A; Bertolino A; Rucci P; Gibertoni D; Montemagni C; Bellino S; Aguglia E; Amore M; Bellomo A; Biondi M; Carpiniello B; Cuomo A; D'Ambrosio E; dell'Osso L; Girardi P; Marchesi C; Monteleone P; Montemitro C; Oldani L; Pacitti F; Roncone R; Siracusano A; Tenconi E; Vita A; Zeppegno P; Steardo L; Vignapiano A; Maj M;
    Schizophr Res; 2018 Nov; 201():105-112. PubMed ID: 29898819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A large European, multicenter, multinational validation study of the Brief Negative Symptom Scale.
    Mucci A; Vignapiano A; Bitter I; Austin SF; Delouche C; Dollfus S; Erfurth A; Fleischhacker WW; Giordano GM; Gladyshev I; Glenthøj B; Gütter K; Hofer A; Hubeňák J; Kaiser S; Libiger J; Melle I; Nielsen MØ; Papsuev O; Rybakowski JK; Sachs G; Üçok A; Wojciak P; Galderisi S
    Eur Neuropsychopharmacol; 2019 Aug; 29(8):947-959. PubMed ID: 31255394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polish version of the Brief Negative Symptom Scale (BNSS).
    Wójciak P; Górna K; Domowicz K; Jaracz K; Gołębiewska K; Michalak M; Rybakowski J
    Psychiatr Pol; 2019 Jun; 53(3):541-549. PubMed ID: 31522195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Brief Negative Symptom Scale (BNSS): Independent validation in a large sample of Italian patients with schizophrenia.
    Mucci A; Galderisi S; Merlotti E; Rossi A; Rocca P; Bucci P; Piegari G; Chieffi M; Vignapiano A; Maj M;
    Eur Psychiatry; 2015 Jul; 30(5):641-7. PubMed ID: 25758156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Individual negative symptoms and domains - Relevance for assessment, pathomechanisms and treatment.
    Kaiser S; Lyne J; Agartz I; Clarke M; Mørch-Johnsen L; Faerden A
    Schizophr Res; 2017 Aug; 186():39-45. PubMed ID: 27453425
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Measurement of negative and depressive symptoms: Discriminatory relevance of affect and expression.
    Richter J; Hölz L; Hesse K; Wildgruber D; Klingberg S
    Eur Psychiatry; 2019 Jan; 55():23-28. PubMed ID: 30384108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inverse association between negative symptoms and body mass index in chronic schizophrenia.
    Mezquida G; Savulich G; Garcia-Rizo C; Garcia-Portilla MP; Toll A; Garcia-Alvarez L; Bobes J; Mané A; Bernardo M; Fernandez-Egea E
    Schizophr Res; 2018 Feb; 192():69-74. PubMed ID: 28412089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improving Knowledge on Pathways to Functional Outcome in Schizophrenia: Main Results From the Italian Network for Research on Psychoses.
    Giuliani L; Giordano GM; Bucci P; Pezzella P; Brando F; Galderisi S
    Front Psychiatry; 2021; 12():791117. PubMed ID: 34970172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Negative symptoms and everyday functioning in schizophrenia: a cross-sectional study in a real world-setting.
    Rocca P; Montemagni C; Zappia S; Piterà R; Sigaudo M; Bogetto F
    Psychiatry Res; 2014 Aug; 218(3):284-9. PubMed ID: 24814140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.